Hypoglycaemia, commonly called low blood sugar, occurs when the glucose circulating in your bloodstream drops below the level your body and brain need to function properly. In people with diabetes, the widely used clinical threshold is a blood glucose reading at or below 70 mg/dL (3.9 mmol/L), the point at which the body’s hormonal defence system normally kicks in to push glucose back up.1Diabetes Care. Defining and Reporting Hypoglycemia in Diabetes But the story is far more layered than a single number on a glucose meter, because the symptoms, severity, and consequences of hypoglycaemia vary enormously depending on how fast glucose drops, how often it has dropped before, and whether the person even notices it happening.
How the Body Normally Defends Against Low Blood Sugar
Your body has a cascading series of defences against falling glucose. Normally, postabsorptive blood glucose sits between roughly 72 and 108 mg/dL. As glucose starts to drift downward, the pancreas dials back insulin secretion at around 81 mg/dL. If levels keep falling to about 65–70 mg/dL, stress hormones like glucagon and epinephrine ramp up to mobilise stored sugar from the liver. Symptoms and measurable cognitive impairment typically appear only if glucose drops further, to roughly 50–55 mg/dL.2Diabetes Care. Hypoglycemia in Diabetes
This stepwise defence works well in healthy people. The trouble starts when one or more of those steps fails, which is exactly what happens with insulin-treated diabetes. Injected insulin does not automatically switch off when glucose falls, so the first line of defence is already gone. And in many cases, the hormonal backup systems become blunted over time, especially in people who experience frequent lows.
What Low Blood Sugar Actually Feels Like
The symptoms of hypoglycaemia split broadly into two categories that reflect different underlying mechanisms. Neurogenic symptoms come from the body’s adrenaline-driven stress response: shakiness, a pounding heart, sweating, hunger, anxiety, and tingling. Neuroglycopenic symptoms come from the brain itself running short of fuel: difficulty thinking, confusion, weakness, drowsiness, and a sensation of warmth.3Diabetes. Mechanism of Awareness of Hypoglycemia: Perception of Neurogenic (Predominantly Cholinergic) Rather Than Neuroglycopenic Symptoms
In practice, the neurogenic symptoms tend to arrive first and serve as your warning system. They are uncomfortable but useful: your body is telling you to eat something now. The neuroglycopenic symptoms are the more dangerous set, because by the time confusion or impaired thinking sets in, you may no longer have the clarity to help yourself. Research has shown that it is the neurogenic symptoms, particularly the cholinergic ones like sweating and hunger, that drive conscious awareness that blood sugar is low.4Diabetes. Mechanism of Awareness of Hypoglycemia: Perception of Neurogenic (Predominantly Cholinergic) Rather Than Neuroglycopenic Symptoms Lose those warning signals, and hypoglycaemia becomes far more dangerous.
When the Warning System Breaks Down
One of the most consequential features of repeated hypoglycaemia is that the body adapts to it in exactly the wrong way. After recurrent low blood sugar episodes, the glucose thresholds at which you start feeling symptoms shift downward. Your body essentially recalibrates, so you no longer experience the shaking, sweating, or hunger that used to warn you at 55 mg/dL; now those signals might not appear until you hit 45 mg/dL or lower.5PubMed. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness This is known as hypoglycaemia unawareness, and it creates a vicious cycle.
The underlying mechanism is called hypoglycaemia-associated autonomic failure, or HAAF. A recent episode of low blood sugar reduces the epinephrine response to the next episode, which means both the hormonal defence and the neurogenic warning symptoms are dulled. The person then fails to recognise or correct the low, has another episode, and the thresholds shift even further down.6Diabetes. Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes People with tightly controlled type 1 diabetes are especially vulnerable, precisely because tight control increases the frequency of mild lows that feed this cycle.7PubMed Central. Hypoglycemia Unawareness-A Review on Pathophysiology and Clinical Implications
The encouraging news is that hypoglycaemia unawareness is at least partly reversible. Studies in people with type 1 diabetes have demonstrated that strictly avoiding blood glucose levels below 4 mmol/L (72 mg/dL) for weeks to months can restore the body’s ability to sense lows, primarily by improving sensitivity to adrenaline-like signals.8PubMed. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes One case report documented full reversal of unawareness after a year of careful avoidance.9PubMed. Reversal of hypoglycemia unawareness in a long-term type 1 diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia In practice, though, pulling this off requires a period of running blood sugar somewhat higher than ideal, which creates tension with the goal of preventing long-term complications from high glucose.
What Hypoglycaemia Does to the Brain
Glucose is the brain’s primary fuel, and the brain cannot store much of it, so even brief interruptions in supply matter. Mild hypoglycaemia tends to impair complex cognitive tasks before simple ones: verbal fluency, arithmetic, reaction time, and memory all suffer when blood glucose falls into the range of roughly 47–60 mg/dL.10IntechOpen. Hypoglycemia and Brain: The Effect of Energy Loss on Neurons These effects are typically reversible once glucose comes back up. You might feel foggy or slow for a while after a low, but your neurons recover.
Severe, prolonged hypoglycaemia is a different matter. It can cause functional brain failure, a state where the brain effectively shuts down but can still be rescued by restoring glucose. In rare extreme cases, profound hypoglycaemia causes irreversible brain damage through mechanisms that go beyond simple fuel deprivation.11PubMed Central. Hypoglycemia, functional brain failure, and brain death The distinction matters: the vast majority of hypoglycaemic episodes, even severe ones, do not cause permanent brain injury if treated. The window for intervention is wider than many people fear.
Children may be more vulnerable. In neonates with congenital hyperinsulinism, a condition where the pancreas overproduces insulin, about a third experienced adverse neurodevelopmental outcomes. Critically, the strongest predictors of serious brain injury were a blood glucose nadir below 20 mg/dL and any delay between the first symptoms and initiation of treatment. Each unit increase in blood glucose reduced the odds of brain injury by about 15%.12PubMed Central. Risk Factors for Adverse Neurodevelopment in Transient or Persistent Congenital Hyperinsulinism The takeaway for parents and clinicians is that speed matters: catching and treating a severe low quickly is the single most important factor in preventing lasting harm.
The Problem of Nocturnal Hypoglycaemia
Roughly half of all severe hypoglycaemic episodes in people with type 1 diabetes happen at night during sleep.13Endocrine Practice. Nocturnal Hypoglycemia: Clinical Manifestations and Therapeutic Strategies Toward Prevention This is a problem for an obvious reason: you cannot eat a glucose tablet if you are asleep and unaware that anything is wrong. Nighttime lows are frequently asymptomatic, meaning blood sugar drops and recovers (or doesn’t recover) without the person ever waking up.
In the worst cases, nocturnal hypoglycaemia has been linked to seizures, coma, and a phenomenon called “dead-in-bed syndrome,” where apparently healthy young people with type 1 diabetes are found dead in an undisturbed bed. The suspected mechanism involves hypoglycaemia triggering a fatal cardiac arrhythmia during sleep.14Endocrine Practice. Nocturnal Hypoglycemia: Clinical Manifestations and Therapeutic Strategies Toward Prevention Even when nighttime lows are not immediately dangerous, recurrent nocturnal episodes may contribute to the development of hypoglycaemia unawareness by repeatedly exposing the body to lows it never consciously registers.
Cardiovascular Risks
Low blood sugar is not just a problem for the brain. Severe hypoglycaemia can trigger cardiovascular events through the same autonomic surge that produces neurogenic symptoms. The rush of adrenaline and related hormones causes a spike in heart rate, blood pressure, and blood viscosity, while simultaneously promoting vasoconstriction and increased clotting tendency. Together, these changes can precipitate heart rhythm disturbances and myocardial ischaemia, particularly in people who already have underlying heart disease.15PubMed Central. Does hypoglycemia cause cardiovascular events?
This is one reason why guidelines for older adults with diabetes and existing cardiovascular disease tend to recommend somewhat looser blood sugar targets. Pushing for very tight control in someone with coronary artery disease introduces a risk of severe hypoglycaemia that can be just as dangerous as the high blood sugar you are trying to prevent.
Hypoglycaemia Without Diabetes
While diabetes treatment is by far the most common cause of clinically significant hypoglycaemia, it is not the only one. Several other conditions can drive blood sugar dangerously low.
Gastric bypass surgery is an increasingly recognised cause. After Roux-en-Y gastric bypass, food empties from the small stomach pouch into the intestine much faster than normal. This rapid delivery of nutrients provokes an exaggerated insulin response, partly driven by amplified secretion of gut hormones like GLP-1. In some patients, this leads to a syndrome of postprandial hypoglycaemia that can appear years after the surgery. People affected tend to have larger spikes and deeper crashes in blood sugar after meals compared to bypass patients who do not develop symptoms.16PubMed Central. Postprandial hypoglycemia after gastric bypass surgery: from pathogenesis to diagnosis and treatment
Insulinomas, rare tumours of the insulin-producing cells in the pancreas, are another non-diabetic cause. They account for the majority of pancreatic neuroendocrine tumours. About 90% are benign and solitary, with only about 10% being malignant. These tumours secrete insulin regardless of the body’s actual glucose level, leading to fasting hypoglycaemia that can be difficult to diagnose because the symptoms mimic many other conditions. Elevated fasting insulin, C-peptide, and proinsulin levels in the setting of low blood glucose are the diagnostic hallmarks.17PubMed Central. Insulinoma: Presenting as hypoglycemia in a non-diabetic patient
Kidney failure is yet another trigger. Hypoglycaemia in people with advanced kidney disease often signals multi-organ decline and carries a poor prognosis. The causes are frequently layered: impaired drug clearance means that medications like insulin or oral glucose-lowering drugs linger longer in the body; reduced kidney function disrupts gluconeogenesis (the kidney is actually one of the body’s secondary glucose-producing organs); and coexisting problems like malnutrition, liver disease, sepsis, or alcohol use can pile on additional risk.18PubMed. Hypoglycemia associated with renal failure Certain medications that are not obviously glucose-related, including beta-blockers and salicylates, have also been implicated in uremic hypoglycaemia.
Treating a Severe Low When You Cannot Eat
The standard first-line treatment for mild hypoglycaemia is straightforward: consume 15–20 grams of fast-acting carbohydrate, wait 15 minutes, recheck, and repeat if needed. The challenge arises when hypoglycaemia is severe enough that the person cannot safely swallow, typically because they are confused, semiconscious, or unconscious. In those situations, glucagon is the rescue treatment.
Traditionally, glucagon came as a powder that had to be mixed with a diluent using a syringe, a multi-step process that is stressful and error-prone in an emergency. Nasal glucagon, approved in recent years, changed the landscape by eliminating the mixing and injection steps entirely. A meta-analysis comparing intranasal and injectable glucagon found no significant difference in effectiveness, with both formats achieving near-complete treatment success rates.19PubMed. Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis A separate comparison of two ready-to-use glucagon formats, nasal and a pre-mixed injectable, found similar success rates of about 99% for both.20Diabetes. 138-OR: Indirect Treatment Comparison of Ready-to-Use Glucagon Rescue Treatments for Severe Hypoglycemia
Where nasal glucagon showed a clear advantage was usability. Because bystanders were more likely to successfully administer the nasal form, modelling estimated that using nasal glucagon could save close to $1,000 per severe episode by reducing the need for emergency services, translating to over a million dollars in reduced spending per 10,000 people with type 1 diabetes over two years.21PubMed Central. Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis The practical upshot: if you live with someone who uses insulin, having an easy-to-use glucagon rescue device within reach is a safety measure worth taking seriously.
How Technology Is Changing Prevention
Continuous glucose monitors and insulin pumps have altered the hypoglycaemia landscape more than any single drug development in recent decades. A continuous glucose monitor alone provides trend arrows showing the direction glucose is heading, with alerts that can wake you before a nighttime low becomes dangerous. Pairing a monitor with an insulin pump goes further: sensor-augmented pumps can automatically suspend insulin delivery when glucose is falling or predicted to fall below a set threshold.22PubMed Central. Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes
The most advanced iteration is the closed-loop or “artificial pancreas” system, in which an algorithm adjusts insulin delivery automatically based on real-time glucose readings. In a six-month multicenter trial of 24/7 closed-loop control in people with type 1 diabetes, time spent below 3.9 mmol/L dropped from about 4% at baseline to roughly 1.3%.23PubMed. Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery Similar systems have now been tested in adults with type 2 diabetes on intensive insulin regimens, with time in hypoglycaemic ranges meeting non-inferiority standards compared to standard care.24JAMA Network Open. Automated Insulin Delivery in Adults With Type 2 Diabetes These systems do not eliminate hypoglycaemia entirely, but they meaningfully reduce it, especially overnight.
The Psychology of Fear
The physical dangers of hypoglycaemia are well documented, but the psychological toll deserves attention too. Many people who have experienced a bad low develop a deep, lasting fear of it happening again. When that fear becomes overwhelming, it can drive avoidance behaviours: deliberately running blood sugar higher than recommended, reducing insulin doses, overeating “just in case,” or avoiding physical activity. Clinicians have described this pattern as the “hypoglycaemic fear syndrome,” recognising it as a distinct clinical problem that leads to chronically elevated glucose levels and, over time, a higher risk of diabetes complications.25Clinical Diabetes. The Hypoglycemic Fear Syndrome: Understanding and Addressing This Common Clinical Problem in Adults With Diabetes
The irony is bitter: fear of hypoglycaemia leads to high blood sugar, which leads to complications, which leads to more intensive treatment, which leads to more hypoglycaemia risk. Breaking out of this cycle often requires more than just adjusting medication. Structured education programmes, psychological support, and the use of continuous glucose monitoring to provide real-time reassurance can all help. For many people, simply seeing a trend arrow pointing flat at 110 mg/dL on a monitor provides a level of confidence that no amount of finger-prick testing could.
Insulin Coma Therapy and What It Taught Us
One of the stranger chapters in the history of hypoglycaemia is its deliberate use as a psychiatric treatment. From the 1930s through the 1950s, “insulin coma therapy” was widely used to treat schizophrenia. Patients were given large doses of insulin to induce prolonged, deep hypoglycaemia and coma, under the theory that the shock to the nervous system would somehow reset disordered brain function. The treatment was hailed as a breakthrough and practised in hospitals around the world. But scepticism about the evidence existed from the beginning, and randomised trials conducted in the 1950s eventually found no meaningful benefit over other treatments or simple sedation.26PubMed Central. ‘A landmark in psychiatric progress’? The role of evidence in the rise and fall of insulin coma therapy The practice was abandoned, but it stands as a cautionary example of how a dangerous intervention can persist for decades when the professional culture is slow to demand rigorous evidence. It also gave researchers some of the earliest detailed clinical descriptions of what progressive hypoglycaemia does to the human brain, observations that informed much of the neuroglycopenic symptom research that followed.